| Robert B Wenzel, MA LPC | |
|
4360 Montebello Dr Ste 400, Colorado Springs, CO 80918-7224 | |
| (719) 593-9228 | |
| (719) 598-1705 |
| Full Name | Robert B Wenzel |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 4360 Montebello Dr Ste 400, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003092727 | NPI | - | NPPES |
| 532691 | Medicaid | CO | |
| 12018498 | Other | CO | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 3204 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert B Wenzel, MA LPC 4360 Montebello Dr Ste 400, Colorado Springs, CO 80918-7224 Ph: (719) 593-9228 | Robert B Wenzel, MA LPC 4360 Montebello Dr Ste 400, Colorado Springs, CO 80918-7224 Ph: (719) 593-9228 |
News Archive
Researchers from Holst Centre and imec have demonstrated the first ever X-ray detector produced on a plastic substrate that is capable of medical-grade performance. The proof-of-concept device delivers high-resolution, dynamic images at 25 frames per second (fps) and 200 pixels per inch (ppi) with high contrast using medical-level X-ray doses.
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its research in AI for drug discovery at BioCentury China HealthCare Summit in Shanghai, 13-14 of November.
Encapsulating human stem-cell-derived beta cells in microcapsules made with a protein that repels key immune cells restored glucose metabolism in diabetic mice and protected the cells from immune system attack, preventing the buildup of inflammatory fibrotic tissue that has plagued previous trials of encapsulated beta cells.
A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
› Verified 4 days ago
Elizabeth Anne Beck, LPC CAC III Counselor Medicare: Not Enrolled in Medicare Practice Location: 2790 N Academy Blvd, Suite 206, Colorado Springs, CO 80917 Phone: 719-596-1530 Fax: 719-559-1130 | |
Andrea Wood, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 435 Gold Pass Hts, Colorado Springs, CO 80906 Phone: 719-205-2671 Fax: 719-632-2342 | |
Norma Dejesus, Counselor Medicare: Not Enrolled in Medicare Practice Location: 179 Parkside Dr, Colorado Springs, CO 80910 Phone: 719-572-6300 | |
Sheila Kelly, Counselor Medicare: Not Enrolled in Medicare Practice Location: 115 Parkside Dr, Colorado Springs, CO 80910 Phone: 719-572-6340 | |
Dawn Zink, MA LPC NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4975 Austin Bluffs Pkwy, Colorado Springs, CO 80918 Phone: 719-301-5488 | |
Melissa Beth Smart, LPC Counselor Medicare: Medicare Enrolled Practice Location: 1330 Inverness Dr Ste 400, Colorado Springs, CO 80910 Phone: 970-310-3406 |